Substance / Medication

Dorzolamide

Overview

Active Ingredient
dorzolamide
RxNorm CUI
60207

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

22 trials linked to this intervention

22
Total Trials
0
Recruiting
6
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Intraocular pressure-lowering effect of adding dorzolamide or latanoprost to timolol: a meta-analysis of randomized clinical trials.
Webers Carroll A B, van der Valk Rikkert, Schouten Jan S A G et al. · Ophthalmology · 2007
PMID: 17070584Meta-Analysis
Comparison of Dorzolamide and Netarsudil on Intraocular Pressure and Ocular Perfusion in Early Glaucoma: A Randomized Controlled Trial.
Angmo Dewang, Jain Vanaja, Warjri Gazella Bruce et al. · J Glaucoma · 2025
PMID: 40719703RCT
Topical dorzolamide for macular holes: A randomised, double-blind, placebo-controlled trial.
Lee Yong Min, Bahrami Bobak, Baranage Duleepa et al. · Clin Exp Ophthalmol · 2024
PMID: 39145570RCT
Dorzolamide nanoliposome as a long action ophthalmic delivery system in open angle glaucoma and ocular hypertension patients.
Kouchak Maryam, Malekahmadi Mohammad, Bavarsad Neda et al. · Drug Dev Ind Pharm · 2018
PMID: 28956449RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dorzolamide (substance)
SNOMED CT
373447009
UMLS CUI
C0165590
RxNorm CUI
60207

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
22
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.